186 related articles for article (PubMed ID: 8795441)
1. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
[TBL] [Abstract][Full Text] [Related]
2. gamma-L-glutamyl-5-hydroxy-L-tryptophan, but not gamma-L-glutamyl-L-tryptophan, causes sodium retention in normal man.
Li Kam Wa TC; Freestone S; Samson RR; Johnson NR; Lee MR
Br J Clin Pharmacol; 1996 Sep; 42(3):365-70. PubMed ID: 8877028
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the renal and neuroendocrine effects of two 5-hydroxytryptamine renal prodrugs in normal man.
Li Kam Wa TC; Freestone S; Samson RR; Johnson NR; Lee MR
Clin Sci (Lond); 1993 Nov; 85(5):607-14. PubMed ID: 8287650
[TBL] [Abstract][Full Text] [Related]
4. Effect of gamma-L-glutamyl-L-dopa on phosphate excretion.
Sadiq S; Berndt TJ; Nath KA; Knox FG
J Lab Clin Med; 2000 Jan; 135(1):52-6. PubMed ID: 10638694
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the renal actions of gamma-L-glutamyl-L-dopa and gamma-L-glutamyl-L-tyrosine in normal man.
Jeffrey RF; MacDonald TM; Lee MR
Clin Sci (Lond); 1988 Jan; 74(1):37-40. PubMed ID: 3123118
[TBL] [Abstract][Full Text] [Related]
6. gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.
de Toledo FG; Thompson MA; Bolliger C; Tyce GM; Dousa TP
Kidney Int; 1999 May; 55(5):1832-42. PubMed ID: 10231445
[TBL] [Abstract][Full Text] [Related]
7. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
Pestana M; Soares-da-Silva P
Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
[TBL] [Abstract][Full Text] [Related]
8. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
Jeffrey RF; MacDonald TM; Marwick K; Lee MR
Br J Clin Pharmacol; 1988 Feb; 25(2):195-201. PubMed ID: 3129006
[TBL] [Abstract][Full Text] [Related]
9. Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man.
Wa TC; Burns NJ; Williams BC; Freestone S; Lee MR
Br J Clin Pharmacol; 1995 Mar; 39(3):327-9. PubMed ID: 7619676
[TBL] [Abstract][Full Text] [Related]
10. The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.
MacDonald TM; Jeffrey RF; Lee MR
Br J Clin Pharmacol; 1989 Jun; 27(6):811-22. PubMed ID: 2527048
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, bioavailability, metabolism, tissue distribution and urinary excretion of gamma-L-glutamyl-L-dopa in the rat.
Cummings J; Matheson LM; Maurice L; Smyth JF
J Pharm Pharmacol; 1990 Apr; 42(4):242-6. PubMed ID: 1974290
[TBL] [Abstract][Full Text] [Related]
12. (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.
MacDonald TM; Jeffrey RF; Freestone S; Lee MR
Br J Clin Pharmacol; 1988 Feb; 25(2):203-12. PubMed ID: 3129007
[TBL] [Abstract][Full Text] [Related]
13. Suppression of noradrenaline spillover by the dopamine prodrug gamma-L-glutamyl-L-dopa: a central effect?
McGrath BP; Wang ZQ; Shimizu K; Way D; Secombe J
Hypertens Res; 1995 Jun; 18 Suppl 1():S113-8. PubMed ID: 8529039
[TBL] [Abstract][Full Text] [Related]
14. Disposition of gamma-glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers.
Boateng YA; Barber HE; MacDonald TM; Petrie JC; Lee MR
Br J Clin Pharmacol; 1991 Apr; 31(4):419-22. PubMed ID: 1904753
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man.
Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
Br J Clin Pharmacol; 1993 Jul; 36(1):19-23. PubMed ID: 7690583
[TBL] [Abstract][Full Text] [Related]
16. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
17. Method for the determination of gamma-L-glutamyl-L-dihydroxyphenylalanine and its major metabolites L-dihydroxyphenylalanine, dopamine and 3,4-dihydroxyphenylacetic acid by high-performance liquid chromatography with electrochemical detection.
Cummings J; Matheson LM; Smyth JF
J Chromatogr; 1990 Jun; 528(1):43-53. PubMed ID: 2117019
[TBL] [Abstract][Full Text] [Related]
18. Sympatho-inhibitory effects of r-l-glutamyl-l-dopa in conscious rabbits.
Wang ZQ; Shimizu K; Way D; Secombe J; McGrath BP
Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):17-21. PubMed ID: 8010078
[TBL] [Abstract][Full Text] [Related]
19. Beneficial acute effects of selective modulation of renal dopamine system by gamma-L-glutamyl-L-dopa in rabbits with congestive heart failure.
Wang ZQ; Way D; Shimizu K; Fong F; Trigg L; McGrath BP
J Cardiovasc Pharmacol; 1993 Jun; 21(6):1004-11. PubMed ID: 7687706
[TBL] [Abstract][Full Text] [Related]
20. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.
Worth DP; Harvey JN; Brown J; Worral A; Lee MR
Br J Clin Pharmacol; 1986 May; 21(5):497-502. PubMed ID: 3087398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
